Immune Checkpoint Inhibitor and Radiotherapy-Related Pneumonitis: An Informatics Approach to Determine Real-World Incidence, Severity, Management, and Resource Implications

Immune Checkpoint Inhibitor and Radiotherapy-Related Pneumonitis: An Informatics Approach to Determine Real-World Incidence, Severity, Management, and Resource Implications

Pneumonitis is a well-described, potentially life-threatening adverse effect of immune checkpoint inhibitors (ICI) and thoracic radiotherapy. It can require additional investigations, treatment, and interruption of cancer therapy. It is important for clinicians to have an awareness of its incidence...

Full description

Bibliographic Details
Main Authors: Sumeet Hindocha, Des Campbell, Merina Ahmed, Kyriaki Giorgakoudi, Bhupinder Sharma, Nadia Yousaf, Philip Molyneaux, Benjamin Hunter, Hardeep Kalsi, Wanyuan Cui, Michael Davidson, Jaishree Bhosle, Anna Minchom, Imogen Locke, Fiona McDonald, Mary O'Brien, Sanjay Popat, Richard W. Lee
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-11-01
Series:Frontiers in Medicine
Subjects:
pneumonitis
immunotherapy
checkpoint inhibitor
radiotherapy
informatics
health economics
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2021.764563/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2021.764563/full

Similar Items